New Mouth-Dissolving treatment tested for aggressive brain cancer recurrence
Disease control
Recruiting now
This study is testing whether adding a new experimental medicine called APG-157, taken as dissolving pastilles in the mouth, can improve outcomes for people whose high-grade glioma (a type of aggressive brain tumor) has returned after previous treatment. Participants will take th…
Phase: PHASE1, PHASE2 • Sponsor: Aveta Biomics, Inc. • Aim: Disease control
Last updated Apr 07, 2026 14:35 UTC